GALECTIN THERAPEUTICS INC - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - November 9, 2012

Attached files
FileFilename
10-Q - FORM 10-Q - GALECTIN THERAPEUTICS INCd402747d10q.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR33.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A) - GALECTIN THERAPEUTICS INCd402747dex312.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - GALECTIN THERAPEUTICS INCd402747dex321.htm
EX-10.3 - EMPLOYMENT AGREEMENT - GALECTIN THERAPEUTICS INCd402747dex103.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A) - GALECTIN THERAPEUTICS INCd402747dex311.htm
EXCEL - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR6.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR9.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR2.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR5.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR3.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR1.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR7.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR8.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR4.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR21.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR14.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR17.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR23.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR29.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR32.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR26.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR18.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR10.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR24.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR20.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR15.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR28.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR13.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR16.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR19.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR27.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR12.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR11.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR25.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR31.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR22.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - GALECTIN THERAPEUTICS INCd402747dex322.htm
v2.4.0.6
Common Stock and Warrant Offering and Reverse Split - Additional Information (Detail) (USD $)
 1 Months Ended
Mar. 22, 2012
Mar. 23, 2012
Mar. 28, 2012
Sep. 30, 2012
Dec. 31, 2011
Aug. 31, 2010
May 31, 2010
Apr. 30, 2009
Stockholders Equity [Line Items]                
Stock issued, shares 1,159,445   1,333,361          
Common share issued 2     15,966,437 12,919,538      
Warrant to purchase common stock 1              
Option to purchase additional units to cover over-allotments 45 days              
Additional units authorize for issuance 173,916              
Public Offering price $ 9.00              
Exercise price of warrant 5.63         4.26 15.00 3.00
Expiration date of warrant Mar. 28, 2017              
Issuance of common stock and warrants     2,666,722          
Warrants to purchase shares of common stock     1,333,361     100,000 12,000 33,333
Gross proceeds from issuance of stock and warrants     $ 12,000,000          
Net proceeds from issuance of stock and warrants     10,403,000          
Stock issued during stock splits   3,324            
Reverse stock split ratio   0.1667            
Warrant one
                
Stockholders Equity [Line Items]                
Price per share of warrants     $ 5.63          
Warrants to purchase shares of common stock     1,333,361          
Value of warrants     4,445,000          
Closing price of warrant issued     $ 4.20          
Warrant, expected life     5 years          
Warrant, volatility rate     119.00%          
Warrant, risk free interest rate     1.05%          
Warrant two
                
Stockholders Equity [Line Items]                
Exercise price of warrant     5.63          
Expiration date of warrant     May 02, 2016          
Warrants to purchase shares of common stock     46,378          
Value of warrants     $ 143,000          
Closing price of warrant issued     $ 4.20          
Warrant, expected life     4 years 1 month 6 days          
Warrant, volatility rate     117.00%          
Warrant, risk free interest rate     0.78%          

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by GALECTIN THERAPEUTICS INC and has no official or unofficial affiliation with GALECTIN THERAPEUTICS INC


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.